罗力亚, 刘翠青, 耿丽洁, 刘姗姗, 张伟伟, 张帅. 不同剂量阿托伐他汀对高龄急性脑梗死患者血管内皮功能的影响[J]. 实用临床医药杂志, 2021, 25(16): 103-106, 111. DOI: 10.7619/jcmp.20211235
引用本文: 罗力亚, 刘翠青, 耿丽洁, 刘姗姗, 张伟伟, 张帅. 不同剂量阿托伐他汀对高龄急性脑梗死患者血管内皮功能的影响[J]. 实用临床医药杂志, 2021, 25(16): 103-106, 111. DOI: 10.7619/jcmp.20211235
LUO Liya, LIU Cuiqing, GENG Lijie, LIU Shanshan, ZHANG Wei, ZHANG Shuai. Effect of different doses of atorvastatin on vascular endothelial function in elderly patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(16): 103-106, 111. DOI: 10.7619/jcmp.20211235
Citation: LUO Liya, LIU Cuiqing, GENG Lijie, LIU Shanshan, ZHANG Wei, ZHANG Shuai. Effect of different doses of atorvastatin on vascular endothelial function in elderly patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(16): 103-106, 111. DOI: 10.7619/jcmp.20211235

不同剂量阿托伐他汀对高龄急性脑梗死患者血管内皮功能的影响

Effect of different doses of atorvastatin on vascular endothelial function in elderly patients with acute cerebral infarction

  • 摘要:
      目的   观察不同剂量阿托伐他汀对高龄急性脑梗死患者血管内皮功能的影响。
      方法   根据随机数字表法将100例高龄急性脑梗死患者分为A组和B组,每组50例。A组给予20 mg/d阿托伐他汀, B组给予60 mg/d阿托伐他汀。比较2组血管内皮功能、血脂指标、斑块厚度、神经功能缺损程度及用药安全性。
      结果   治疗后, 2组血管舒张反应(FMD)、一氧化氮(NO)高于治疗前,内皮素(ET)低于治疗前,且B组FMD、NO高于A组,ET低于A组,差异有统计学意义(P < 0.05); 2组甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)低于治疗前,高密度脂蛋白胆固醇(HDL-C)高于治疗前,且B组TG、TC、LDL-C低于A组, HDL-C高于A组,差异有统计学意义(P < 0.05); 2组颈动脉内膜中层厚度(IMT)、神经功能缺损评分(NIHSS)均低于治疗前,且B组低于A组,差异有统计学意义(P < 0.05)。2组患者治疗期间无严重不良反应发生。
      结论   与低剂量相比,高剂量阿托伐他汀改善高龄急性脑梗死患者血脂、血管内皮功能效果更优,可减轻神经缺损程度,且具有一定安全性。

     

    Abstract:
      Objective   To observe the effect of different doses of atorvastatin on vascular endothelial function in elderly patients with acute cerebral infarction.
      Methods   According to random number table method, 100 elderly patients with acute cerebral infarction were divided into group A and group B, with 50 cases in each group. The group A was given 20 mg/d atorvastatin, while the group B was given 60 mg/d atorvastatin. Vascular endothelial function, blood lipid indexes, plaque thickness, neurological deficit degree and medication safety were compared between the two groups.
      Results   After treatment, flow-mediated vasodilation (FMD) and nitric oxide (NO) in two groups were significantly higher than those before treatment, endothelin (ET) was significantly lower than that before treatment, FMD and NO in the group B were significantly higher, and ET in the group B was significantly lower than those in the group A (P < 0.05); the triglyceride (TG), total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) in two groups were significantly lower than those before treatment, the high-density lipoprotein cholesterol (HDL-C) was significantly higher than that before treatment, and TG, TC and LDL-C in the group B were significantly lower, and HDL-C was significantly higher than that in the group A (P < 0.05); the carotid intima media thickness (IMT) and the score of National Institutes of Health Stroke Scale (NIHSS) in two groups were significantly lower than those before treatment, and the above indicators in the group B were significantly lowerthan those in the group A (P < 0.05). No serious adverse reactions occurred in two groups during treatment.
      Conclusion   Compared with lose-dose atorvastatin, high-dose atorvastatin has better effects on blood lipid and vascular endothelial function in elderly patients with acute cerebral infarction, can reduce the degree of nerve defect and has certain safety.

     

/

返回文章
返回